pubmed-article:10746906 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10746906 | lifeskim:mentions | umls-concept:C0014507 | lld:lifeskim |
pubmed-article:10746906 | lifeskim:mentions | umls-concept:C0338656 | lld:lifeskim |
pubmed-article:10746906 | lifeskim:mentions | umls-concept:C0683325 | lld:lifeskim |
pubmed-article:10746906 | pubmed:issue | 2 Suppl 1 | lld:pubmed |
pubmed-article:10746906 | pubmed:dateCreated | 2000-4-27 | lld:pubmed |
pubmed-article:10746906 | pubmed:abstractText | Subclinical cognitive impairment is commonly reported in elderly populations, but its clinical significance is largely undetermined. It is commonly perceived as a normal feature of the aging process or a separate nosological entity. The clinical status of this disorder is explored herein by reference to longitudinal observations. It is concluded that persons with subclinical cognitive impairment constitute a highly heterogeneous group. There is an elevated risk in this group for senile dementia, with an estimated 18% incidence rate over 3 years, but in the majority of cases, this problem is more commonly associated with depressive symptomatology and physical illness. Only 13% of persons with recent observable change in cognitive functioning appear to have a totally benign and transient syndrome. Caution should be exercised in applying single unifying nosological entities such as age-associated memory impairment to this group of the elderly. | lld:pubmed |
pubmed-article:10746906 | pubmed:language | eng | lld:pubmed |
pubmed-article:10746906 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10746906 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10746906 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10746906 | pubmed:issn | 0010-440X | lld:pubmed |
pubmed-article:10746906 | pubmed:author | pubmed-author:RitchieKK | lld:pubmed |
pubmed-article:10746906 | pubmed:author | pubmed-author:TouchonJJ | lld:pubmed |
pubmed-article:10746906 | pubmed:author | pubmed-author:LedésertBB | lld:pubmed |
pubmed-article:10746906 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10746906 | pubmed:volume | 41 | lld:pubmed |
pubmed-article:10746906 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10746906 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10746906 | pubmed:pagination | 61-5 | lld:pubmed |
pubmed-article:10746906 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:10746906 | pubmed:meshHeading | pubmed-meshheading:10746906... | lld:pubmed |
pubmed-article:10746906 | pubmed:meshHeading | pubmed-meshheading:10746906... | lld:pubmed |
pubmed-article:10746906 | pubmed:meshHeading | pubmed-meshheading:10746906... | lld:pubmed |
pubmed-article:10746906 | pubmed:meshHeading | pubmed-meshheading:10746906... | lld:pubmed |
pubmed-article:10746906 | pubmed:meshHeading | pubmed-meshheading:10746906... | lld:pubmed |
pubmed-article:10746906 | pubmed:meshHeading | pubmed-meshheading:10746906... | lld:pubmed |
pubmed-article:10746906 | pubmed:meshHeading | pubmed-meshheading:10746906... | lld:pubmed |
pubmed-article:10746906 | pubmed:meshHeading | pubmed-meshheading:10746906... | lld:pubmed |
pubmed-article:10746906 | pubmed:meshHeading | pubmed-meshheading:10746906... | lld:pubmed |
pubmed-article:10746906 | pubmed:meshHeading | pubmed-meshheading:10746906... | lld:pubmed |
pubmed-article:10746906 | pubmed:meshHeading | pubmed-meshheading:10746906... | lld:pubmed |
pubmed-article:10746906 | pubmed:meshHeading | pubmed-meshheading:10746906... | lld:pubmed |
pubmed-article:10746906 | pubmed:meshHeading | pubmed-meshheading:10746906... | lld:pubmed |
pubmed-article:10746906 | pubmed:meshHeading | pubmed-meshheading:10746906... | lld:pubmed |
pubmed-article:10746906 | pubmed:meshHeading | pubmed-meshheading:10746906... | lld:pubmed |
pubmed-article:10746906 | pubmed:articleTitle | Subclinical cognitive impairment: epidemiology and clinical characteristics. | lld:pubmed |
pubmed-article:10746906 | pubmed:affiliation | Institut National de la Santé et de la Recherche Médicale (INSERM) E99-30, Montpellier, France. | lld:pubmed |
pubmed-article:10746906 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10746906 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10746906 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10746906 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10746906 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10746906 | lld:pubmed |